Home Tags Vaccinations

Vaccinations Related Content

Pfizer vaccine, COVID

Independent FDA Committee says Pfizer vaccine is ready for the US

The independent experts of the FDA say the Pfizer vaccine is good to go, which means that the COVID vaccine should be formally approved in a matter of days.
COVID-19 vaccinations, astrazeneca

Historic COVID-19 vaccinations begin in the UK

Margaret Keenan, a 90 year old former jewellery shop assistant, becomes the first person to receive a COVID-19 vaccination in the UK.
COVID-19 vaccine

Pfizer COVID-19 vaccine to be rolled out across UK next week

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the Pfizer/BioNTech COVID-19 vaccine for use in the UK and will be made available as early as next week.
moderna vaccine, phase three

The Moderna vaccine has a final efficiency of 94.1%

The clinical trials are over for the Moderna vaccine - the company announced their drug was 94.1% effective and then filed for Emergency Use.
astrazeneca vaccine, efficient

AstraZeneca vaccine makes mistake in dose calculation

The Oxford and AstraZeneca vaccine trial gave an accidental half-dose to 3,000 people - but this mistake is the reason the vaccine acted as 90% efficient.
COVID-19 mutation, sars

COVID-19 mutation does not make virus more infectious

Researchers at University College London have found that COVID-19 mutations do not make the virus more likely to spread, as previously feared.
COVID-19 vaccine, TRIPS agreement

TRIPS agreement: A waiver makes the COVID-19 vaccine more accessible

Rachel Thrasher, Research Fellow at the Global Development Policy Center in Boston, says this time is different and the TRIPS Council knows it - the COVID-19 vaccine needs to be freely accessible to all countries.
astrazeneca vaccine, covid

Oxford and AstraZeneca vaccine is 70.4% effective

The UK's answer to Pfizer and Moderna, the Oxford and AstraZeneca vaccine, has proven to be exactly 70.4% effective against COVID-19.
vaccine in december, drug

US healthcare workers could get Pfizer vaccine in December

Today (20 November) Pfizer and BioNTech are sending their drug for approval to the FDA, meaning that the most vulnerable Americans could get the vaccine in December.
aymptomatic older patients, delirium

Delirium could be a sign of COVID-19 in asymptomatic older patients

Asymptomatic older patients of COVID-19 are one of the most difficult to identify - now, researchers find that delirium could be an indicator of the virus
oxford COVID vaccine, immunisation

Oxford COVID vaccine creates strong immunisation in older people

New data from the Oxford COVID vaccine trial shows that the UK antidote is working well at Phase two, with defining percentages expected after Phase Three is complete.

The role of pharmacy during COVID-19

Gino Martini, RPS Chief Scientist and the Science and Research Team at the Royal Pharmaceutical Society reflect on the role of pharmacy during COVID-19 in delivering accessible, safe and effective care for all.

COVID-19: Solidarity is needed the most

European Public Health Association Executive Director, Dineke Zeegers Paget examines COVID-19 as a societal issue, not just a pandemic and argues that solidarity here is needed the most.
300 million doses, pfizer

European Commission buys 300 million doses of Pfizer vaccine

While the US and UK sealed their BioNTech and Pfizer vaccine deals within 24 hours of the new results, the European Commission took 3 days longer to secure their larger order of 300 million doses.
pfizer vaccine, astrazeneca

The Pfizer vaccine: When will people in the UK get it?

Yesterday, at 6:45am in the US, the Pfizer vaccine was revealed to be over 90% effective - so when will the successful drug be available for the UK to use?
Pfizer vaccine, COVID-19

Pfizer vaccine is more than 90% successful in preventing COVID-19

Created without US Government funding, the BioNTech and Pfizer vaccine is revealed to be over 90% effective against COVID-19.
patients with diabetes, COVID-19

Impact of COVID-19 on healthcare for patients with diabetes

Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group considers how the standard of healthcare for patients with diabetes is impacted by COVID-19.
child migrants, disease

ICE detention centres withheld vaccines from child migrants

Over 12 US Immigration and Customs Enforcement (ICE) detention centres had multiple outbreaks of infectious disease - due to withholding vaccines for adult and child migrants.
UK COVID-19 vaccine, china

When is the UK COVID-19 vaccine going to be ready?

While AstraZeneca and Oxford University continue to work on a UK COVID-19 vaccine, what about the rest of the world?
hydroxychloroquine, COVID

Research finds hydroxychloroquine does not work against COVID-19

A study published in Clinical Infectious Diseases found that hydroxychloroquine did not work to protect healthcare professionals from COVID-19.

Follow Open Access Government